No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr13:51416200-51418400 |
Active TSS |
Brain Dorsolateral Prefrontal Cortex |
brain
|
2 |
chr13:51416400-51418600 |
Flanking Active TSS |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
3 |
chr13:51416800-51418400 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
4 |
chr13:51417000-51418400 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
5 |
chr13:51417000-51418400 |
Active TSS |
Brain Substantia Nigra |
brain
|
6 |
chr13:51417000-51418400 |
Enhancers |
Fetal Heart |
heart
|
7 |
chr13:51417000-51418600 |
Active TSS |
Brain Inferior Temporal Lobe |
brain
|
8 |
chr13:51417400-51418400 |
Enhancers |
Fetal Brain Male |
brain
|
9 |
chr13:51417800-51418400 |
Flanking Active TSS |
Fetal Thymus |
thymus
|
10 |
chr13:51417800-51419000 |
Flanking Active TSS |
Dnd41 |
blood
|
11 |
chr13:51418000-51418400 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
12 |
chr13:51418000-51418400 |
Flanking Bivalent TSS/Enh |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
13 |
chr13:51418000-51418400 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
14 |
chr13:51418000-51418400 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
15 |
chr13:51418000-51418400 |
Enhancers |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
16 |
chr13:51418000-51418400 |
Weak transcription |
Aorta |
Aorta
|
17 |
chr13:51418000-51418400 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
18 |
chr13:51418000-51418400 |
Bivalent Enhancer |
NHDF-Ad |
bronchial
|
19 |
chr13:51418000-51418600 |
Flanking Active TSS |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
20 |
chr13:51418000-51418800 |
Enhancers |
Thymus |
Thymus
|
21 |
chr13:51418000-51419400 |
Bivalent Enhancer |
Muscle Satellite Cultured Cells |
--
|
22 |
chr13:51418000-51419800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
23 |
chr13:51418000-51420600 |
Weak transcription |
Psoas Muscle |
Psoas
|
24 |
chr13:51418000-51421000 |
Weak transcription |
Liver |
Liver
|
25 |
chr13:51418200-51418400 |
Flanking Active TSS |
H9 Cell Line |
embryonic stem cell
|
26 |
chr13:51418200-51418400 |
Bivalent Enhancer |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
27 |
chr13:51418200-51418400 |
Flanking Bivalent TSS/Enh |
HUES64 Cell Line |
embryonic stem cell
|
28 |
chr13:51418200-51418400 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
29 |
chr13:51418200-51418400 |
Flanking Active TSS |
Brain Angular Gyrus |
brain
|
30 |
chr13:51418200-51418400 |
Flanking Active TSS |
Brain Germinal Matrix |
brain
|
31 |
chr13:51418200-51418400 |
Flanking Active TSS |
Fetal Kidney |
kidney
|
32 |
chr13:51418200-51418400 |
Enhancers |
Fetal Muscle Trunk |
muscle
|
33 |
chr13:51418200-51418600 |
Flanking Active TSS |
Fetal Brain Female |
brain
|
34 |
chr13:51418200-51418800 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
35 |
chr13:51418200-51419000 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
36 |
chr13:51418200-51419000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
37 |
chr13:51418200-51419000 |
Enhancers |
HSMM |
muscle
|
38 |
chr13:51418200-51419200 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
39 |
chr13:51418200-51419200 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
40 |
chr13:51418200-51419600 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
41 |
chr13:51418200-51419800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
42 |
chr13:51418200-51420200 |
Weak transcription |
Primary T cells from cord blood |
blood
|
43 |
chr13:51418200-51420400 |
Weak transcription |
Primary B cells from cord blood |
blood
|
44 |
chr13:51418200-51420400 |
Weak transcription |
Primary B cells from peripheral blood |
blood
|
45 |
chr13:51418200-51421000 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|